Abstract
The central mechanism of stress is poorly understood. This study was designed to examine how corticotropin-releasing factor (CRF) neurons, together with substance P (SP) receptors in the paraventricular hypothalamic nucleus (PVN), central nucleus of the amygdala (CeA), and locus coeruleus (LC), are affected by stress. Sprague-Dawley rats were restrained for 2 h. Animals were sacrificed by decapitation immediately after the 2-h restraint (the 0-h group) and 4, 24, or 48 h after restraint. Tissue sections were cut and collected on two sets of slides. Tissue sections of the first set were processed for studying CRF mRNA using 33P-labeled 60-mer oligonucleotide probe. Immediately adjacent tissue sections were processed for studying SP receptor-binding capacity using 125I-SP ligand. Quantitative results showed that CRF mRNAs in the PVN were significantly up-regulated at the 4- and 24-h stages, and they seemed not to be regulated by SP receptors. In addition, SP receptors in the CeA were up-regulated at the 24- and 48-h stages, whereas SP receptors were down-regulated in the LC at the same stages. In concert with the literature indicating SP antagonist’s antidepressive effects, up-regulated SP receptors in the CeA might contribute to the development of stress-related depression.
Similar content being viewed by others
References
Albeck D. S., McKittrick C. R., Blanchard D. C., Blanchard R. J., Nikulina J., McEwen B. S., and Sakai R. R. (1997) Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J. Neurosci. 17, 4895–4903.
Aston-Jones G. and Bloom F. E. (1981) Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J. Neurosci. 1, 887–900.
Baby S., Nguyen M., Tran D., and Raffa R. B. (1999) Substance P antagonists: the next breakthrough in treating depression? J. Clin. Pharm. Ther. 24, 461–469.
Brody M. J. (1988) Central nervous system and mechanisms of hypertension. Clin. Physiol. Biochem. 6, 230–239.
Brown M. R., Koob G. F., and Rivier C., eds. (1991) Stress: Neurobiology and Neuroendocrinology, Marcel Dekker, New York.
Buijs R. M., Geffard M., Pool C. W., and Hoorneman E. M. D. (1984) The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopic study. Brain Res. 323, 65–72.
Chowdhury G. M., Fujioka F., and Nakamura S. (2000) Induction and adaptation of Fos expression in the rat brain by two types of acute restraint stress. Brain Res. Bull. 52, 171–182.
Conley R. K., Cumberbatch M. J., Mason G. S., Williamson D. J., Harrison T., Locker K., et al. (2002) Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J. Neurosci. 22, 7730–7736.
Culman J., Kopin I. J., and Saavedra J. M. (1991) Regulation of corticotropin-releasing hormone and pituitary-adrenocortical response during acute and repeated stress in the rat. Endocrinol. Regul. 25, 151–158.
Cunningham E. T. Jr. and Sawchenko P. E. (1988) Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274, 60–76.
Curzon G. (1989) 5-Hydroxytryptamine and corticosterone in an animal model of depression. Prog. Nueropsychopharmacol. Biol. Psychiatry 13, 305–310.
da Costa A. P., Ma X. M., Ingram C. D., Lightman S. L., and Aguilera G. (2001) Hypothalamic and amygdaloid corticotropin-releasing hormone (CRH) and CRH receptor-1 mRNA expression in the stress-hyporesponsive late pregnant and early lactating rat. Mol. Brain Res. 91, 119–130.
Davis M. (1992) The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15, 353–375.
De Souza E. B. and Van Loon G. R. (1982) Stress-induced inhibition of the plasma corticosterone response to subsequent stress in rats: a nonadrenocorticotropin-mediated mechanism. Endocrinology 110, 23–33.
Duncko R., Kiss A., Skultetyova I., Rusnak M., and Jezova D. (2001) Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychneuroendocrinology 26, 77–89.
File S. E. (1997) Anxiolytic action of a neurokinin 1 receptor antagonist in the social interaction test. Pharmacol. Biochem. Behav. 58, 747–752.
Gehlert D. R., Schober D. A., Hipskind P. A., Gitter B. D., and Howbert J. J. (1996) [3H]LY303870, a novel nonpeptide radioligand for the NK1 receptor. J. Neurochem. 66, 1095–1102.
Givalois L., Arancibia S., and Tapia-Arancibia L. (2000) Concomitant changes in CRH mRNA level in rat hippocampus and hypothalamus following immobilization stress. Mol. Brain Res. 75, 166–171.
Glavin G. B., Pare W. P., Sandbak T., Bakke H. K., and Murison R. (1994) Restraint stress in biochemical research: an update. Neurosci. Biobehav. Rev. 18, 223–249.
Gray T. S., Carney M. E., and Magnuson D. J. (1989) Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50, 433–446.
Gray T. S., O’Donohue L., and Magnuson D. J. (1986) Neuropeptide Y innervation of amygdaloid and hypothalamic neurons that project to the dorsal vagal complex in rat. Peptides 7, 341–249.
Hand, G. A., Hewitt, C. B., Fulk, L. J., Stock, H. S. Carson, J. A. et al. (2002) Differential release of corticotropin-releasing hormone (CRH) in the amygdala during different types of stressors. Brain Res. 949, 122–130.
Harbuz M. S., Chalmers J., De Souza L., and Lightman S. L. (1993) Stress-induced activation CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res. 609, 167–173.
Hatalski C. G., Guirguis C., and Baram T. Z. (1998) Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat. J. Neuroendocrinol. 10, 663–669.
Heinrichs S. C., Li D. L., and Iyengar S. (2001) Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Res. 900, 177–185.
Hewson L., Hunt S., Rupniak N., and Smith D. (2000) “Reduced tyrosine hydroxylase immunoreactivity in the locus coeruleus of NK1 receptor knockout mice,” Tachykinins 2000, International Tachykinin Conference, La Grande Motte, France, P-67.
Hwang B. H.and Guntz J. M. (1997) Downregulation of corticotropin-releasing factor mRNA, but not vasopressin mRNA, in the paraventricular hypothalamic nucleus of rats following nutritional stress. Brain Res. Bull. 43, 509–514.
Hwang B. H. and Wang G. M. (1993) A rapid and sensitive radioimmunohistochemical assay for quantitation of vasopressin in discrete brain regions with an anatomical resolution. J. Neurosci. Methods 50, 37–44.
Hwang B. H., Froehlich J. C., Hwang W. S., Lumeng L., and Li T. K. (1998) More vasopressin mRNA in the paraventricular hypothalamic nucleus of alcohol-preferring rats and high alcohol-drinking rats, selectively bred for high alcohol preference. Alcohol. Clin. Exp. Res. 22, 664–669.
Hwang B. H., Kunkler P. E., Lumeng L., and Li T. K. (1995) Calcitonin gene-related peptide (CGRP) content and CGRP receptor binding sites in discrete forebrain regions of alcohol-preferring vs. -nonpreferring rats, and high alcohol-drinking vs. low alcohol-drinking rats. Brain Res. 690, 249–253.
Imaki T., Naruse M., Harada S., Chikada N., Imaki J., Onodera H., et al. (1996) Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Mol. Brain Res. 38, 166–170.
Kalin N. H., Takahashi L. K., and Chen F. L. (1994) Restraint stress increases corticotropin-releasing factor mRNA content in the amygdala and paraventricular nucleus. Brain Res. 656, 182–186.
Kash A. and Schioth H. B. (2000) Tonic inhibition of food intake during inactive phase is reversed by the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat. Brain Res. 887, 460–464.
Katz R. J. (1982) Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16, 965–968.
Koegler-Muly S. M., Owens M. J., Ervin G. N., Kilts C. D., and Nemeroff C. B. (1993) Potential corticotropin-releasing factor pathway in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 5, 95–98.
Koob G.F. (1999a) Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 46, 1167–1180.
Koob G.F. (1999b) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann. N. Y. Acad. Sci. 877, 445–460.
Kramer M.S., Cutler N., Feifhner J., Shrivastava R., Carman J. et al. (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 1640–1645.
Kupfermann I (1991) Hypothalamus and limbic system; peptidergic neurons, homeostasis and emotional behavior, in Principles of Neural Science, 3rd ed. Kandel, E. R., Schwartz, J. H., and Jessell, T. M., eds., Elsevier, New York, pp. 735–749.
Levine S. and Ursin H. (1991) What is stress? in Stress: Neurobiology and Neuroendocrinology, Brown, M.R., Koob, G. F., and Rivier, C., eds., Marcel Dekker, New York, pp. 3–21.
Lightman S. L., Harbuz M. S., Knight R. A., and Chowdrey H. S. (1993) CRF mRNA in normal and stress conditions. Ann. N.Y. Acad. Sci. 697, 28–38.
Loewy A. D. and McKellar S. (1980) The neuroanatomical basis of central cardiovascular control. Fed. Proc. 39, 2495–2503.
Makino S. and Gold P. W. (1994) Effects of corticosterone on CRF mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res. 657, 141–149.
Manning B. H. and Mayer D. J. (1995) The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J. Neurosci. 15, 8199–8213.
Maubach K. A., Rupniak N. M., Kramer M. S., and Hill R. G. (1999) Novel strategies for pharmacotherapy of depression. Curr. Opin. Chem. Biol. 3, 481–488.
McBride W. J. (2002) Central nucleus of the amygdala and the effects of alcohol and alcohol-drinking behavior in rodents. Pharmacol. Biochem. Behav. 71, 509–515.
McEwen B. S. and Magarinos A. M. (1997) Stress effects on morphology and function of the hippocampus. Ann. N.Y. Acad. Sci. 821, 271–284.
Mendelson S. D. and McEwen B. S. (1991) Autoradiographic analysis of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 54, 454–461.
Merchenthaler I., Vigh S., Petrusz P., and Schally A. V. (1982) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am. J. Anat. 165, 385–396.
Miyata K., Ito H., and Fukudo S. (1998) Involvement of the 5-HT3 receptor in CRF-induced defecation in rats. Am. J. Physiol. 274, G827-G831.
Okano S., Nagaya H., Ikeura Y., Natsugari H., and Inatomi N. (2001) Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo. J. Pharmacol. Exp. Ther. 298, 559–564.
Palkovits M., Brownstein M. J., and Vale W. (1985) Distribution of corticotropin-releasing factor in rat brain. Fed. Proc. 44, 215–219.
Palkovits M. (2000) Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur. J. Pharmacol. 405, 161–166.
Papp M., Vassout A., and Gentsch C. (2000) The NK1 receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav. Brain Res. 115, 19–23.
Pare W. P. and Redei E. (1993) Depressive behavior and stress ulcer in Wistar Kyoto rats. J. Physiol. 87, 229–238.
Pawlak, R., Magarinos, A. M., Melchor, J., McEwen, B., and Strickland, S. (2003) Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat. Neurosci. 6, 168–174.
Pepin M. C., Pothier F., and Barden N. (1992) Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42, 991–995.
Pinnock S. B. and Herbert J. (2001) Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress. Eur. J. Pharmacol. 13, 576–584.
Plotsky P. M. and Meaney M. J. (1993) Early, postnatal experience alters hypothalamic corticotropin-releasing (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol. Brain Res. 18, 195–200.
Pucilowski O., Overstreet D. H., Rezvani A. H., and Janowsky D. S. (1993) Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol. Behav. 54, 1215–1220.
Quirion R. and Dam T. V. (1986) Ontogeny of substance P receptor binding sites in rat brain. J. Neurosci. 6, 2187–2199.
Ranga K. and Krishnan R. (2002) Clinical experience with substance P receptor (NK1) antagonists in depression. J. Clin. Psychiatry 63(Suppl. 11), 25–29.
Richter R. M., Zorrilla E. P., Basso A. M., Koob F. G., and Weiss F. (2000) Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study. Alcohol. Clin. Exp. Res. 24, 1765–1772.
Rothman R. B., Herkenham M., Pert C. B., Liang T., and Cascieri M. A. (1984) Visualization of rat brain receptors for the neuropeptide, substance P. Brain Res. 309, 47–54.
Sawchenko P. E. (1991) The final common path, in Stress: Neurobiology and Neuroendocrinology, Brown, M. R., Koob, G. F., and Rivier, C., eds., Marcel Dekker, New York, pp. 55–71.
Suemaru S., Hashimoto K., and Ota Z. (1985) Brain corticotropin-releasing factor (CRF) and catecholamine responses in acutely stressed rats. Endocrinol. Japonica 32, 709–718.
Suemaru S., Hashimoto K, Hattori T., Inoue H. Kageyama J., and Ota Z. (1986) Starvation-induced changes in rat brain corticotropin-releasing factor (CRF) and pituitary-adrenocortical response. Life Sci. 39, 1161–1166.
Swanson L. W., Sawchenko P. E., Rivier J., and Vale W. W. (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165–186.
Ungerstedt U. (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. Suppl. 367, 1–48.
Van Bockstaele E. J., Bajic D., Proudfit H., and Valentino R. J. (2001) Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol. Behav. 73, 273–283.
Viau V. and Sawchenko P. E. (2002) Hypophysiotrophic neurons of the paraventricular nucleus respond in spatially, temporally, and phenotypically differentiated manners to acute vs. repeated restraint stress: rapid publication. J. Comp. Neurol. 445, 293–307.
Volz H. P., Rehben G., Trieoel J., Knuepfer M. M., Stumpf H., and Stock G. (1990) Afferent connections of the nucleus centralis amygdalae. Anat. Embryol. 181, 177–194.
Weiner H. (1991) Behavioral biology of stress and psychosomatic medicine, in Stress: Neurobiology and Neuroendocrinology, Brown, M. R., Koob, G. F., and Rivier, C., eds., Marcel Dekker, New York, pp. 23–51.
Author information
Authors and Affiliations
Corresponding author
Additional information
Parts of the results have been presented at the summer neuropeptide conference (June 8–12, 2003, Montauk, NY) as P-37 (Neuropeptides [2003] 37, 192).
Rights and permissions
About this article
Cite this article
Hwang, B.H., Katner, J. & Iyengar, S. Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of sprague-dawley rats following restraint-induced stress. J Mol Neurosci 25, 239–250 (2005). https://doi.org/10.1385/JMN:25:3:239
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:25:3:239